Adenovirus-mediated gene transfer into cold-preserved liver allografts: Survival pattern and unresponsiveness following transduction with CTLA4Ig

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Nature Medicine

• Publication date

  1998-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nm0298-194PMID 9461193
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage.

  1997cited by this paper
• Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs

  1996cited by this paper
• Immune responses to transgene–encoded proteins limit the stability of gene expression after injection of replication–defective adenovirus vectors

  1996cited by this paper
• The in vivo mechanism of action of CTLA4Ig.

  1996cited by this paper
• Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo.

  1996cited by this paper
• Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection.

  1996cited by this paper
• Adenovirus-mediated gene transfer in the transplant setting. Part III. Variables affecting gene transfer in liver grafts: Drazan KE, Wu L, Shen X, Bullington D, Jurim O, Busuttil RW, Shaked A. Transplantation 1995; 59: 670–673

  1995cited by this paper
• CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2

  1995cited by this paper
• Hepatic function is preserved following liver-directed, adenovirus-mediated gene transfer.

  1995cited by this paper
• The generation of transgenic pigs as potential organ donors for humans

  1995cited by this paper
• Adenovirus-mediated gene transfer in the transplant setting. Part III. Variables affecting gene transfer in liver grafts.

  1995cited by this paper
• In vivo adenoviral-mediated human p53 tumor suppressor gene transfer and expression in rat liver after resection.

  1994cited by this paper
• Adenovirus-mediated gene transfer in the transplant setting. I. Conditions for expression of transferred genes in cold-preserved hepatocytes.

  1994cited by this paper
• CTLA4Ig prolongs allograft survival while suppressing cell-mediated immunity.

  1994cited by this paper
• RETROVIRAL‐MEDIATED GENE TRANSFER INTO RAT EXPERIMENTAL LIVER TRANSPLANT

  1994cited by this paper
• Adenovirus-mediated gene transfer in the transplant setting. II. Successful expression of transferred cDNA in syngeneic liver grafts.

  1994cited by this paper
• Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion

  1993cited by this paper
• The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice.

  1993cited by this paper
• Mice lacking major histocompatibility complex class I and class II molecules.

  1993cited by this paper
• Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule.

  1992cited by this paper
• Gene transfer and expression in rat cardiac transplants.

  1992cited by this paper
• EFFECTS OF COTRANSPLANTED FETAL LIVER ON FETAL PANCREAS ISOGRAFTS 1, 2.

  1992cited by this paper
• Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg.

  1992cited by this paper
• Experimental heterotopic heart transplantation without ischemia or reperfusion.

  1990cited by this paper
• ORTHOTOPIC LIVER TRANSPLANTATION IN THE RAT: TECHNIQUE USING CUFF FOR PORTAL VEIN ANASTOMOSIS AND BILIARY DRAINAGE

  1979cited by this paper
• A new technique for the assay of infectivity of human adenovirus 5 DNA.

  1973cited by this paper
• Selective extraction of polyoma DNA from infected mouse cell cultures.

  1967cited by this paper

• Designer Organs: Ethical Genetic Modifications in the Era of Machine Perfusion.

  2025cites this paper
• Gene Delivery Followed by Ex Vivo Lung Perfusion using an Adeno-Associated Viral Vector in a Rodent Lung Transplant Model.

  2023cites this paper
• AAV9-mediated gene delivery to liver grafts during static cold storage in a rat liver transplant model

  2023cites this paper
• Gene Therapy: Will the Promise of Optimizing Lung Allografts Become Reality?

  2022cites this paper
• Abatacept treatment for patients with severe acute hepatitis caused by hepatitis B virus infection—Pilot study

  2020cites this paper
• Biopatterned CTLA4/Fc Matrices Facilitate Local Immunomodulation, Engraftment, and Glucose Homeostasis After Pancreatic Islet Transplantation

  2016cites this paper
• Avoiding immunological rejection in regenerative medicine.

  2015cites this paper
• Human Cytotoxic T Lymphocyte-Mediated Acute Liver Failure and Rescue by Immunoglobulin in Human Hepatocyte Transplant TK-NOG Mice

  2015cites this paper
• Chapter 102 – Genetic and Genomic Potential in Liver Transplantation

  2015cites this paper
• Gene therapy modalities in lung transplantation.

  2014cites this paper
• Organomatics and organometrics: Novel platforms for long-term whole-organ culture.

  2014cites this paper
• Adenovirus-Mediated CTLA4Ig Expression and Systemic Mechanisms After Tolerance to Cardiac Allografts Via Local

  2013cites this paper
• Immunobiology of Embryonic and Induced Pluripotent Stem Cell Transplantation

  2013cites this paper
• Hepatocytes: A Rodent Model of Responses and Dependent on Apoptosis of in the Liver Is Independent of Immune Lethal Hepatitis After Gene Transfer of IL-4

  2013cites this paper
• The role of normothermic extracorporeal perfusion in minimizing ischemia reperfusion injury.

  2012cites this paper
• Co-Stimulatory Blockade and Tolerance Induction in Transplantation

  2012cites this paper
• Immunology of Liver Transplantation

  2012cites this paper
• Novel Anti-viral Strategies for Hepatitis C

  2012cites this paper
• Ex Vivo Transfer of Adenovirus-Mediated CTLA4Ig Gene Combined with a Short Course of Rapamycin Therapy Prolongs Free Flap Allograft Survival

  2011cites this paper
• AAV-mediated gene therapy for liver diseases: the prime candidate for clinical application?

  2011cites this paper
• Relative efficiency of porcine and human cytotoxic T‐lymphocyte antigen 4 immunoglobulin in inhibiting human CD4+ T‐cell responses co‐stimulated by porcine and human B7 molecules

  2011cites this paper
• Prolonged Xenograft Survival Induced by Inducible Costimulator-Ig Is Associated With Increased Forkhead Box P3+ Cells

  2011cites this paper
• Local Expression of Indoleamine 2,3 Dioxygenase in Syngeneic Fibroblasts Significantly Prolongs Survival of an Engineered Three-Dimensional Islet Allograft

  2010cites this paper
• Gene Transfer of Antisense B7.1 Attenuates Acute Rejection Against Liver Allografts in Rats

  2010cites this paper
• ADENOVIRUS-MEDIATED GENE TRANSFER TO LIVER GRAFTS: AN IMPROVED METHOD TO MAXIMIZE INFECTIVITY1

  2010cites this paper
• The effects of erythropoietin (EPO) and carbon monoxide (CO) on renal ischaemia/reperfusion (I/R) injury in an isolated porcine kidney model

  2009cites this paper
• Gene therapy in transplantation.

  2009cites this paper
• Prospects of RNAi and microRNA-based therapies for hepatitis C

  2009cites this paper
• Gene delivery of indoleamine 2,3‐dioxygenase prolongs cardiac allograft survival by shaping the types of T‐cell responses

  2008cites this paper
• Targeting of interleukin‐10 is superior to cytotoxic T‐lymphocyte associated antigen 4 with human immunoglobulin G1 for the prevention of chronic allograft deterioration in organ transplantation

  2008cites this paper
• Hydroxyethyl starch–based preservation solutions enhance gene therapy vector delivery under hypothermic conditions

  2008cites this paper
• Allograft rejection: acute and chronic studies.

  2008cites this paper
• Induction of Tolerance in Allotransplantation

  2007cites this paper
• Immunomodulation by Adenoviral-Mediated SCD40-Ig Gene Therapy for Mouse Allogeneic Islet Transplantation

  2007cites this paper
• Genetic Modification of Hepatocytes towards Hepatocyte Transplantation and Liver Tissue Engineering

  2006cites this paper
• Adeno-associated virus-mediated CTLA4Ig gene transfer protects MHC-mismatched renal allografts from chronic rejection.

  2006cites this paper
• Lentiviral expression of CTLA4Ig inhibits primed xenogeneic lymphocyte proliferation and cytokine responses

  2006cites this paper
• Gene therapy for transplantation with viral vectors – how much of the promise has been realised?

  2006cites this paper
• Sendai virus-mediated gene delivery into hepatocytes via isolated hepatic perfusion.

  2006cites this paper
• Gene therapy in lung transplantation.

  2006cites this paper
• Avenues for immunomodulation and graft protection by gene therapy in transplantation

  2006cites this paper
• Long-term survival of cardiac allografts induced by cyclophosphamide combined with CTLA4Ig-gene transfer mediated by adenoviral vector.

  2006cites this paper
• Hydrodynamic plasmid DNA gene therapy model in liver transplantation.

  2006cites this paper
• Effect of Adenovirus-Mediated Transfer of the CTLA4IG Gene in Hamster-to-Rat Xenotransplantation

  2005cites this paper
• Adenovirus-Mediated CTLA4Ig or CD40Ig Gene Transfer Delays Pancreatic Islet Rejection in a Rat-to-Mouse Xenotransplantation Model after Systemic but Not Local Expression

  2005cites this paper
• The goal of intragraft gene therapy.

  2005cites this paper
• The evolving role of gene‐based treatment in surgery

  2005cites this paper
• Hepatocyte transplantation

  2005cites this paper
• Genetic Heterogeneity and Efficiency of Two Different Methods of Adenovirus-Mediated Gene Transfer in a Rat Liver Transplantation Model

  2005cites this paper
• Augmentation of transgene expression in cold-preserved organs using vascular endothelial growth factor receptor-mediated adenoviral vector combined with hyperbaric oxygen.

  2005cites this paper
• 83 – Genetic Modulation in Transplantation

  2005cites this paper
• Basic concepts in transplant immunology

  2005cites this paper
• Genetic modification in organ transplantation and in vivo luciferase imaging

  2005cites this paper
• Gene therapy for prevention and treatment of type 1 diabetes

  2005cites this paper
• Transplantation tolerance by donor MHC gene transfer.

  2004cites this paper
• Gene therapy: how to target the kidney. Promises and pitfalls.

  2004cites this paper
• Kidney transplantation : strategies to prevent organ rejection

  2004cites this paper
• ROLE OF THE THYMUS IN TRANSPLANTATION TOLERANCE IN MINIATURE SWINE: IV. THE THYMUS IS REQUIRED DURING THE INDUCTION PHASE, BUT NOT THE MAINTENANCE PHASE, OF RENAL ALLOGRAFT TOLERANCE1

  2004cites this paper
• Ex vivo adenovirus-mediated gene transfer to corneal graft endothelial cells in mice.

  2004cites this paper
• Gene therapy for heart transplantation-associated acute rejection, ischemia/reperfusion injury and coronary arteriosclerosis.

  2004cites this paper
• Favorable Effect of Cotransfection with TGF-β and CTLA4Ig of the Donor Kidney on Allograft Survival

  2004cites this paper
• Patterns of transgene expression and viral clearance from the transplanted liver following ex vivo adenovirus-mediated gene transfer.

  2004cites this paper
• Time course of gene expression after the injection of adenoviral vectors containing CTLA4IG gene.

  2004cites this paper
• DNA immunization of the grafted liver by particle-mediated gene gun1

  2003cites this paper
• Optimal modes and targets of gene therapy in transplantation

  2003cites this paper
• Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft.

  2003cites this paper
• Simultaneous administration of a low‐dose mixture of donor bone marrow cells and splenocytes plus adenovirus containing the CTLA4Ig gene result in stable mixed chimerism and long‐term survival of cardiac allograft in rats

  2003cites this paper
• CTLA4Ig Adenoviral Gene Transfer Induces Long-Term Islet Rat Allograft Survival, Without Tolerance, After Systemic but Not Local Intragraft Expression

  2003cites this paper
• Renal gene transfer

  2003cites this paper
• Feline Immunodeficiency Virus‐Mediated Viral Interleukin‐10 Gene Transfer Prolongs Non‐Vascularized Cardiac Allograft Survival

  2003cites this paper
• Intragraft gene and protein expression in rat liver allografts treated with costimulatory blockade alone or in combination with CyA.

  2003cites this paper
• Immunological Characteristics of Pancreas Transplantation: Review and Our Experimental Experience

  2003cites this paper
• Theoretical and technical considerations for gene transfer into vascularized cardiac transplants.

  2003cites this paper
• Genetic modification of cold-preserved renal grafts using HSP70 or bcl-2 HVJ-liposome method.

  2003cites this paper
• Difficulty of achieving long-term graft survival of MHC-disparate composite graft using CTLA4IG.

  2003cites this paper
• CTLA4Ig-gene transfection with FTY720 administration markedly inhibits the obliterative airway disease in heterotopically transplanted rat tracheas.

  2003cites this paper
• Trends in organ preservation

  2003cites this paper
• Ex vivo and systemic transfer of adenovirus-mediated CTLA4Ig gene combined with a short course of FK506 therapy prolongs islet graft survival.

  2003cites this paper
• A novel gene therapy to the graft organ by a rapid injection of naked DNA I: long-lasting gene expression in a rat model of limb transplantation

  2003cites this paper
• Induction of donor-specific tolerance by adenovirus-mediated cd40ig gene therapy in rat liver transplantation1

  2002cites this paper
• Combined therapy of CTLA4Ig-gene transfection with FTY720 administration in rat lung allografts.

  2002cites this paper
• FasL-transfected endothelial cells decrease the proliferative response of allogeneic PBL.

  2002cites this paper
• Cardiac Cell and Gene Transfer

  2002cites this paper
• The role of the graft in establishing tolerance.

  2002cites this paper
• Molecular Pathways of Regeneration and Repair after Liver Transplantation

  2002cites this paper
• Locally expressed CTLA4-Ig in a pancreatic beta-cell line suppresses accelerated graft rejection response induced by donor-specific transfusion

  2002cites this paper
• Costimulatory blockade prevents early rejection, promotes lymphocyte apoptosis, and inhibits the upregulation of intragraft interleukin‐6 in an orthotopic liver transplant model in the rat

  2002cites this paper
• Gene therapy in transplantation.

  2002cites this paper
• Impediments to successful gene transfer to the kidney in the context of transplantation and how to overcome them.

  2002cites this paper
• Gene therapy and solid-organ transplantation.

  2002cites this paper
• Effect of administration of CTLA4-Ig as protein or cDNA on corneal allograft survival.

  2002cites this paper
• Prolonged Blockade of CD40-CD40 Ligand Interactions by Gene Transfer of CD40Ig Results in Long-Term Heart Allograft Survival and Donor-Specific Hyporesponsiveness, But Does Not Prevent Chronic Rejection1

  2002cites this paper
• Targeted gene therapy with CD40Ig to induce long-term acceptance of liver allografts.

  2002cites this paper
• Chronic Rejection Hyporesponsiveness , But Does Not Prevent Survival and Donor-Specific Results in Long-Term Heart Allograft Interactions by Gene Transfer of CD 40 Ig Prolonged Blockade of CD 40-CD 40 Ligand Löwenstein and Ignacio Anegon

  2002cites this paper
• Lethal Hepatitis After Gene Transfer of IL-4 in the Liver Is Independent of Immune Responses and Dependent on Apoptosis of Hepatocytes: A Rodent Model of IL-4-Induced Hepatitis1

  2001cites this paper
• Prospects for genetic manipulation of donor organs and tissues.

  2001cites this paper
• Modified AdCTLA-4 vector blocks alloimmune response in vitro.

  2001cites this paper
• Renal gene therapy.

  2001cites this paper
• Tolerance induction by a single donor pretreatment with the adenovirus vector encoding CTLA4Ig gene in rat orthotopic liver transplantation.

  2001cites this paper
• Extrapancreatic pseudoaneurysm after pancreas transplantation.

  2001cites this paper